News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Emory University : Winship Cancer Institute names Ramalingam new executive director

06/18/2021 | 10:15am EDT

Suresh S. Ramalingam, MD, has been named executive director of Winship Cancer Institute of Emory University.

An internationally renowned thoracic oncologist and physician scientist, Ramalingam has served as Winship's deputy director since 2016. He begins his new post July 1.

Ramalingam takes the helm at a transformational moment for Winship, Georgia's only NCI-designated comprehensive cancer center. He will preside over the largest expansion in Winship's history, including the construction and opening of a new 17-story cancer facility on the campus of Emory University Hospital Midtown. He will also lead Winship as it seeks renewal of its NCI designation.

As executive director, Ramalingam will continue to lead efforts to extend local access to cancer research and care at Emory Healthcare's six hospitals throughout metro-Atlanta, Grady Memorial Hospital, Atlanta VA Medical Center, and Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta.

'Dr. Ramalingam is the ideal person to lead Winship into the future of cancer research and care,' says Jonathan S. Lewin, MD, executive vice president for health affairs at Emory, executive director of Woodruff Health Sciences Center and CEO and chair of the board Emory Healthcare. 'He has been instrumental to our success in seamlessly blending Winship's three missions: research, clinical and education. His collaborative experience and skills will be critical as we enter new frontiers in the world of cancer that will revolutionize the way we treat those who are diagnosed with this deadly disease.'

Ramalingam was selected following a national search led by Lewin with the support of key leaders at Emory. The search produced an impressive array of candidates from across the country, including outstanding external and internal candidates.

'I have been impressed with all I have learned about Winship Cancer Institute during my first year at Emory. It is poised to grow in stature and impact and Dr. Ramalingam has the experience, vision and expertise to cultivate breakthroughs in research and clinical care as we open this exciting new chapter,' says Emory President Gregory L. Fenves.

'For millions across the United States, cancer is all too personal and Dr. Ramalingam - along with his extraordinary colleagues - approaches his lifesaving work at Winship with patients and families at the very heart of all he does.'

Ramalingam's research has focused on the development of individualized therapies for patients with non-small cell lung cancer. He is principal investigator for Winship's Lung Cancer SPORE, an NCI specialized program of research excellence; has published more than 200 peer reviewed studies; and served as president of the Georgia Society of Clinical Oncology. Ramalingam also led the integration of Winship's research, clinical and educational components.

'I am deeply honored by the trust placed in me to lead Winship,' says Ramalingam. 'With its exceptional researchers, physicians, nurses and staff, Winship is well-positioned to make seminal contributions to improving the lives of cancer patients everywhere. Together, we will continue to build Winship's eminence as a destination cancer center, and we will remain steadfast in our dedication to accelerating cures and inspiring hope.'

In addition to his Winship duties, Ramalingam serves as assistant dean for cancer research at Emory University School of Medicine, where he is also professor of hematology and medical oncology, director of the Division of Medical Oncology, and the Roberto C. Goizueta Distinguished Chair for Cancer Research.

Earlier this year, Ramalingam was named to serve as editor-in-chief of CANCER, a peer-reviewed journal of the American Cancer Society. That five-year editorship begins July 1.

Before arriving at Winship in 2007, Ramalingam was an assistant professor at University of Pittsburgh School of Medicine and Wayne State University.

Disclaimer

Emory Healthcare Inc. published this content on 18 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 June 2021 14:14:08 UTC.


© Publicnow 2021
Latest news "Companies"
12:21pFOX News Channel's Gutfeld! Edges out CBS' The Late Show with Stephen Colbert Last Week for Late-Night Ratings Crown
BU
12:19pINNERSCOPE HEARING TECHNOLOGIES (OTC : INND) Announces FDA Has Released The Final Rule For OTC Hearing Aids 
AQ
12:18pHot dogs vs deli meat; rising costs shape choices at Walmart
AQ
12:17pQuarterly Report and Financial Statements
AQ
12:16pSouth African rand gains against dollar ahead of Fed minutes
RE
12:16pWHO vows nothing 'ridiculous' as public submits ideas to rename monkeypox
RE
12:16pNEW PEOPLES BANKSHARES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)
AQ
12:16pBlackRock Greater Europe Investment Trust Plc - Transaction in Own Shares
PR
12:16pCapital Gearing Trust Plc - Issue of Equity
PR
12:16pFidelity Japan Trust Plc - Transaction in Own Shares
PR
Latest news "Companies"